Crystal structure of the BMP-2–BRIA ectodomain complex

  title={Crystal structure of the BMP-2–BRIA ectodomain complex},
  author={Thomas A Kirsch and Walter Sebald and Matthias K Dreyer},
  journal={Nature Structural Biology},
Bone morphogenetic proteins (BMPs) belong to the large transforming growth factor-β (TGF-β) superfamily of multifunctional cytokines. BMP-2 can induce ectopic bone and cartilage formation in adult vertebrates and is involved in central steps in early embryonal development in animals. Signaling by these cytokines requires binding of two types of transmembrane serine/threonine receptor kinase chains classified as type I and type II. Here we report the crystal structure of human dimeric BMP-2 in… 

Type I receptor binding of bone morphogenetic protein 6 is dependent on N‐glycosylation of the ligand

Bone morphogenetic proteins (BMPs), together with transforming growth factor (TGF)‐β and activins/inhibins, constitute the TGF‐β superfamily of ligands, and N‐glycosylation at Asn73 of BMP‐6 in the wrist epitope is crucial for recognition by the activin receptor type I.

Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction

Mutational and interaction analyses indicate that the large hydrophobic core of the interface of BMP-2 (wrist epitope) with the type I receptor does not provide a hydrophilic hot spot for binding, and main chain amide and carbonyl groups that are completely buried in the contact region represent major binding determinants.

Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors*

Although the proregion of BMP-9 remains tightly associated after secretion, it is found, in several cell-based assays, that the activities of B MP-9 and BMP -9·pro-region complex were equivalent.

Molecular recognition of BMP-2 and BMP receptor IA

Bone morphogenetic protein-2 (BMP-2) and other members of the TGF-β superfamily regulate the development, maintenance and regeneration of tissues and organs. Binding epitopes for these extracellular

The Crystal Structure of the BMP-2: BMPR-IA Complex and the Generation of BMP-2 Antagonists

The identification and characterization of the two receptor binding epitopes in BMP-2 provide new insight into the primary steps of B MP-receptor activation and are transferable to other TGF-&bgr; receptor systems.

Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.

The structure-activity relationship of the extracellular ligand-binding domain of the BMP type IA receptor was investigated by alanine-scanning mutagenesis and it was concluded that sBMPR-IA recognizes the ligand using the concave face of the molecule.

Structure of the ternary signaling complex of a TGF-β superfamily member

The results together establish that the specific signaling output is largely determined by two variables, the ligand–receptor pair identity and the mode of cooperative assembly of relevant receptors governed by the lig and flexibility in a membrane-restricted manner.

A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor

The structure-/function studies presented here revealed a new mechanism, in which the energy contribution of a conserved H-bond is modulated by surrounding intramolecular interactions to achieve a switch between low- and high-affinity binding.

Structural basis of BMP signalling inhibition by the cystine knot protein Noggin

The crystal structure of the antagonist Noggin bound to BMP-7 is reported, which shows that Nogsgin inhibits BMP signalling by blocking the molecular interfaces of the binding epitopes for both type I and type II receptors.



Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution.

The crystal structure of human BMP-2 determined by molecular replacement and refined to an R-value of 24.2 % at 2.7 A resolution is reported, showing differences in the flexibility of the N terminus and the orientation of the central alpha-helix as well as two external loops at the fingertips with respect to the scaffold.

Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.

Bone morphogenic proteins appear to require the cooperation of these two receptors for optimal binding and for signal transduction, and the combinatorial nature of these receptors and their capacity to crosstalk with the activin receptor system may underlie the multifunctional nature of their ligands.

Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily.

The three-dimensional structure of osteogenic protein 1 (OP-1), a member of the transforming growth factor beta (TGF-beta) superfamily of proteins, is reported to 2.8-A resolution and it is found that although there is limited sequence identity between OP-1 and TGF- beta 2, they share a common polypeptide fold.

Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity.

The results identify the basic N-terminal domains of dimeric BMP-2 as heparin-binding sites that are not obligatory for receptor activation but modulate its biological activity.

TGF-beta signal transduction.

The transforming growth factor beta (TGF-beta) family of growth factors control the development and homeostasis of most tissues in metazoan organisms and mutations in these pathways are the cause of various forms of human cancer and developmental disorders.

Assignment of Transforming Growth Factor β1 and β3 and a Third New Ligand to the Type I Receptor ALK-1*

The data suggest that HHT pathogenesis involves disruption of a complex network of positive and negative angiogenic factors, involving TGF-β, a new unknown ligand, and their corresponding receptors.

The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding

The structure of TGF‐β3 was solved by X‐ray crystallography and refined to a final R‐factor of 17.5% at 2.0 Å resolution and differences exist in the conformations of the N‐terminal α‐helix and in the β‐sheet loops that might account for the individual cellular responses.

Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.

The 1.5 Å resolution crystal structure of the extracellular ligand-binding domain of the type II activin receptor (ActRII-ECD) is reported, which reveals a fold similar to that of a class of toxins known as three-finger toxins, likely to be shared by most of thetype I and II receptors for the TGFβ family.

Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily.

Sequence profile analysis of other members of the TGF-beta superfamily, including the activins, inhibins, and several developmental factors, imply that they also adopt the T GF-beta fold.